Kbi-058 Direct

Many clinical trials (such as those for Pembrolizumab ) have identifiers like "KEYNOTE-059" or "NCT02690558," but there is currently no major FDA-registered drug or trial under the specific designation "KBI-058".

Some archival search results indicate that "KBI 058" has appeared in ticker-tape or metadata for Kenyan news broadcasts (such as NTV Jioni), likely as a reference code for a specific news segment or geographical reporting zone. Distinguishing from Similar Identifiers KBI-058

Outside of media, the "KBI" prefix is often used in administrative and business reporting, though "KBI-058" as a specific unique identifier for a product or chemical is less common in mainstream scientific literature. Many clinical trials (such as those for Pembrolizumab

In crystallography, complex compounds like In crystallography, complex compounds like It is important

It is important not to confuse with similarly named items in other fields: